News
Safe prescription topical antibiotic alternatives to use on superficial skin infections include Silvadene® cream, Ilotycin® ointment and mupirocin (Bactroban®) 2% ointment and cream (Rietschel ...
Mupirocin 2% ointment (not cream) if blocked pore (bleb) opened. Only if recurrent or persistent culture nipple, areola, milk, and bleb if present.
Mupirocin 2% ointment (not cream) if blocked pore (bleb) opened. Only if recurrent or persistent culture nipple, areola, milk, and bleb if present. Rx with fluconazole (Diflucan) 200-400 mg STAT ...
Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.
Spain agreed with the NATO military alliance to be excluded from spending 5% of its gross domestic product on defence, Prime Minister Pedro Sanchez said on Sunday.
A visual illusion puzzle challenges internet users to find a hidden butterfly. The image features an elderly woman knitting with her cats. Participant ...
2. CRISPR Therapeutics. CRISPR Therapeutics (CRSP 1.67%) stock surged in the year leading up to a major milestone: its first product approval. But since last year's launch of Casgevy, a gene ...
Eurozone inflation fell to 1.9% in May, below forecasts, boosting expectations of an ECB rate cut on Thursday. Core inflation also eased to 2.4%. The euro slipped and bond yields fell as markets ...
Seagate is expected to post earnings of $2.45 per share for the current quarter, representing a year-over-year change of +133.3%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.4%.
Investigational ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild to moderate AD in children 2 years to 5 years old is under review by the FDA with a Prescription Drug User Fee ...
Manitoba Public Insurance has filed an application with the province's Public Utilities Board to raise the cost of insurance by 2.07 per cent, starting next April. The increase would mean the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results